Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies When using antibodies in research or ...
Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...
Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI ...
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...
Antibodies have evolved by nature to possess exquisite selectivity for foreign targets to elicit an effective immune response, making particularly promising strides in advancing drug development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results